title: Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer.
abstract: Phosphatidylinositol 3-kinase (PI3-K)/PTEN/Akt signaling is over activated in various tumors including colon cancer. Activation of this pathway regulates multiple biological processes such as apoptosis, metabolism, cell proliferation, and cell growth that underlie the biology of a cancer cell. In the present study, the chemopreventive effects have been observed of Diclofenac, a preferential COX-2 inhibitory non-steroidal anti-inflammatory drugs, and Curcumin, a natural anti-inflammatory agent, in the early stage of colorectal carcinogenesis induced by 1,2-dimethylhydrazine dihydrochloride in rats. The tumor-promoting role of PI3-K/Akt/PTEN signal transduction pathway and its association with anti-apoptotic family of proteins are also observed. Both Diclofenac and Curcumin downregulated the PI3-K and Akt expression while promoting the apoptotic mechanism. Diclofenac and Curcumin administration significantly increased the expression of pro-apoptotic Bcl-2 family members (Bad and Bax) while decreasing the anti-apoptotic Bcl-2 protein. An up-regulation of cysteine protease family apoptosis executioner, such as caspase-3 and -9, is seen. Diclofenac and Curcumin inhibited the Bcl-2 protein by directly interacting at the active site by multiple hydrogen bonding, as also evident by negative glide score of Bcl-2. These drugs stimulated apoptosis by increasing reactive oxygen species (ROS) generation and simultaneously decreasing the mitochondrial membrane potential (ΔΨ M). Diclofenac and Curcumin showed anti-neoplastic effects by downregulating PI3-K/Akt/PTEN pathway, inducing apoptosis, increasing ROS generation, and decreasing ΔΨ M. The anti-neoplastic and apoptotic effects were found enhanced when both Diclofenac and Curcumin were administered together, rather than individually.
authors: Department of Biophysics, Panjab University, Chandigarh, 160014, India.
authors: Chandan
authors: C
authors: Rana
authors: Honit
authors: H
authors: Piplani
authors: Vivek
authors: V
authors: Vaish
authors: Bimla
authors: B
authors: Nehru
authors: S N
authors: SN
authors: Sanyal
mesh_terms: D019813:1,2-Dimethylhydrazine; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D003106:Colon / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D003474:Curcumin / Q000494:pharmacology*; D004008:Diclofenac / Q000494:pharmacology*; D015536:Down-Regulation; D004354:Drug Screening Assays, Antitumor; D008297:Male; D053078:Membrane Potential, Mitochondrial; D008928:Mitochondria / Q000187:drug effects; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D017382:Reactive Oxygen Species; D004008:Diclofenac; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D051059:PTEN Phosphohydrolase; C487216:Pten protein, rat; D003474:Curcumin; D019813:1,2-Dimethylhydrazine
references: Biochem Pharmacol. 2008 Feb 15;75(4):787-809
references: 17900536
references: Drug Resist Updat. 2007 Feb-Apr;10(1-2):13-29
references: 17303468
references: BMC Struct Biol. 2008 Sep 03;8:38
references: 18768082
references: Annu Rev Biophys Biomol Struct. 2003;32:335-73
references: 12574069
references: Cancer Res. 2003 Apr 1;63(7):1712-21
references: 12670926
references: Nanoscale. 2011 Apr;3(4):1558-67
references: 21283869
references: Eur J Pharmacol. 2012 Mar 5;678(1-3):61-70
references: 22227329
references: Apoptosis. 2003 Aug;8(4):363-70
references: 12815279
references: J Cell Sci. 2001 Jul;114(Pt 13):2375-82
references: 11559746
references: J Natl Cancer Inst. 2004 May 5;96(9):662-72
references: 15126603
references: Nat Rev Cancer. 2002 Jul;2(7):489-501
references: 12094235
references: Nat Rev Cancer. 2003 Oct;3(10):768-80
references: 14570043
references: World J Gastrointest Oncol. 2010 Apr 15;2(4):169-76
references: 21160593
references: Anticancer Res. 2001 Jul-Aug;21(4B):2895-900
references: 11712783
references: Cell. 2004 Jan 23;116(2):205-19
references: 14744432
references: Free Radic Biol Med. 2010 Mar 15;48(6):749-62
references: 20045723
references: Physiol Rev. 2007 Jan;87(1):99-163
references: 17237344
references: Anticancer Agents Med Chem. 2013 Sep;13(7):1014-24
references: 23272911
references: Mol Cell Biol. 2003 Oct;23(20):7315-28
references: 14517300
references: J Biol Chem. 2003 Sep 12;278(37):34783-93
references: 12826665
references: Nat Rev Cancer. 2009 Aug;9(8):550-62
references: 19629070
references: Proc Soc Exp Biol Med. 1962 Dec;111:544-7
references: 14001233
references: J Biol Chem. 2000 Apr 14;275(15):10761-6
references: 10753867
references: Phytomedicine. 2000 Jul;7(4):303-8
references: 10969724
references: Acta Pharmacol Sin. 2007 Sep;28(9):1355-64
references: 17723169
references: Biochim Biophys Acta. 2013 Nov;1830(11):5142-56
references: 23872169
references: Asian Pac J Cancer Prev. 2000;1(2):97-113
references: 12718676
references: Cell Biochem Biophys. 2013 Jun;66(2):205-27
references: 23149858
references: Oncogene. 2006 Sep 14;25(41):5640-7
references: 16619034
references: J Biol Chem. 1999 Apr 23;274(17):11549-56
references: 10206961
references: Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G344-51
references: 15064231
references: Nature. 2000 Oct 12;407(6805):770-6
references: 11048727
references: Clin Cancer Res. 2001 Jul;7(7):1894-900
references: 11448902
references: Mol Carcinog. 2013 Nov;52(11):845-58
references: 22623379
references: Chem Res Toxicol. 1992 Mar-Apr;5(2):227-31
references: 1322737
references: Proc Natl Acad Sci U S A. 1980 Feb;77(2):990-4
references: 6965798
references: Oncogene. 2000 Oct 19;19(44):5083-90
references: 11042696
references: Cancer Biol Ther. 2011 Dec 15;12(12):1032-49
references: 22157148
references: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18081-7
references: 18981409
references: J Biochem. 2012 Mar;151(3):255-61
references: 22287686
references: Cell. 2007 Jun 29;129(7):1261-74
references: 17604717
references: Semin Cell Dev Biol. 2004 Apr;15(2):171-6
references: 15209376
references: Free Radic Biol Med. 2007 Jan 1;42(1):64-78
references: 17157194
references: Oncogene. 2004 Jul 29;23(34):5781-91
references: 15208671
references: Curr Med Chem. 2011;18(18):2763-9
references: 21568903
references: Eur J Cancer Prev. 2013 May;22(3):215-28
references: 23514809
references: Cancer Metastasis Rev. 2010 Sep;29(3):405-34
references: 20737283
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: J Biol Chem. 2005 Oct 28;280(43):36029-36
references: 16129692
references: Int J Biochem Cell Biol. 2009 Jan;41(1):40-59
references: 18662800
references: Oncogene. 2003 Dec 8;22(56):8983-98
references: 14663477
references: Oncogene. 2007 Feb 26;26(9):1324-37
references: 17322918
references: Clin Cancer Res. 2002 Jul;8(7):2024-34
references: 12114400
references: Cell. 1997 Feb 7;88(3):347-54
references: 9039261
references: Mol Cancer Ther. 2005 Jan;4(1):1-11
references: 15657348
references: Nat Med. 2000 Sep;6(9):1024-8
references: 10973323
references: Curr Top Microbiol Immunol. 2010;346:9-29
references: 20563709